Article Details
Retrieved on: 2021-03-11 09:23:34
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The benefits of bispecific antibodies over monoclonal therapeutics are due to their higher binding avidity to targets, which can interact with more than ...
Article found on: ksusentinel.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here